🚨 Breaking from #ESC2025 🚨 New ESC/EAS dyslipidemia guidelines: 🔹 Lp(a) now a risk modifier beyond SCORE2 🔹 New cut off: ≥50 mg/dL (≈105 nmol/L) A big step forward for personalised CV risk assessment and prevention #LipoproteinA #Dyslipidemia #CVD #CVH

Adrenal insufficiency is a syndrome of cortisol deficiency. This Review summarizes the pathophysiology of adrenal insufficiency and approaches to diagnosis, treatment, and prevention of adrenal crisis. ja.ma/4oXJS1G

Prolactinomas are the most prevalent functional pituitary adenomas and can result in a proliferative endocrine disorder that is typically highly responsive to medical therapy thelancet.com/journals/landi… #prolactinomas #hyperprolactinaemia #pituitary

📢 New in JAMA: Clinical Review on #Hypothyroidism Why read it? 🔎 Clear algorithm for dx 💊 Practical LT4 dosing 📆 Monitoring 📦 FAQ: risk factors, initial dose, when to refer ‼️A must-read update for daily practice 👩‍⚕️👨‍⚕️ 🔗 doi:10.1001/jama.2025.13559 #EndoTwitter

Medicamentos que afectan la función tiroidea o interfieren con las pruebas de función tiroidea: JAMA 2025; DOI: 10.1001/jama.2025.13559

An update to the primary aldosteronism guidelines now recommend screening EVERYONE with hypertension for primary aldosteronism. 🩺📑 Why such a broad recommendation? 🤔 Primary aldosteronism is under-recognized as the most common cause of secondary hypertension. ⚡️🫀 It’s

Myo-inositol supplementation DURING pregnancy did not reduce the incidence of a composite of gestational diabetes, preeclampsia, or preterm birth in patients with PCOS JAMA ⬇️ jamanetwork.com/journals/jama/…

🧠🧩Compañeros de #MedicinaInterna de Fundació Salut Empordà publican en RECCMI el caso de un paciente con Sdme de #Fahr (enfermedad neurodegenerativa por calcificaciones cerebrales)2° a hipoparatiroidismo postiroidectomía mal controlado⚠️ #EnfermedadesRaras reccmi.com/RECCMI/article…

Early Statin Use Following Diagnosis of Graves’ Disease Is Associated with a Reduced Risk of Moderate-to-Severe Graves’ Orbitopathy in Middle-Aged Adults: Evidence from a Nationwide Taiwanese Cohort | Thyroid® liebertpub.com/doi/abs/10.117…

Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes In SURPASS-PEDS #EASD2025

AGA guidelines on gastroparesis 🆕 ✅ 1st line: Metoclopramide / erythromycin ✅ Metoclopramide ok for long term use: Start at 5mg TDS + drug holidays ✅ Dx with gastric emptying study ✅ Workup for G-POEM if refractory + >6-12 months of symptoms 📸: gastrojournal.org/article/S0016-…

CUSHING’S SYNDROME & ACC Expert Summit Compartiendo experiencia en la gestión y el diagnóstico: Una mirada a Latinoamérica Chairing: Dr. Jaydira Del Rivero Dr. Valeria de Miguel Dr. Ricardo Correa 24 y 25 de Septiembre 2025 cloud.information.esteve.com/registro-webin…

💢Peripheral Parenteral Nutrition and Personalized Nutritional Approach After Colorectal Resection Surgery: A Comprehensive Review of Current Evidence 👉Esta revisión presenta las tendencias actuales con respecto a la administración de nutrición parenteral periférica (NPP)

A new era in obesity treatment: medications like #semaglutide and #tirzepatide target hunger pathways, offering sustained weight loss of 15–21%. More potent therapies and next-gen biologics, dual and triple agonists, are under development. jamanetwork.com/journals/jama/…

Polycystic ovary syndrome: A metabolic disorder with therapeutic opportunities dlvr.it/TNZsMl Cell Metabolism

Presentación en el congreso SEEN. Granada 2025. #SEEN2025

Orgullosa de mi equipo #EpiEndoNut (IDIS): 🏆 Andrea G. Izquierdo, premio FSEEN al proyecto junior #investigación 🏆 Paula M. Lorenzo, premio FSEEN a la mejor tesis doctoral 🏆 Gemma Rodríguez-Carnero, premio FSEEN a investigacion clinica ¡Gracias #SEEN2025 (Granada)! 💙